Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 16, 2022

SELL
$33.11 - $55.01 $1,986 - $3,300
-60 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$50.07 - $66.05 $600 - $792
12 Added 25.0%
60 $3,000
Q2 2021

Aug 16, 2021

SELL
$56.61 - $80.46 $31,588 - $44,896
-558 Reduced 92.08%
48 $3,000
Q1 2021

Aug 17, 2021

BUY
$86.23 - $125.19 $51,910 - $75,364
602 Added 15050.0%
606 $56,000
Q1 2021

May 12, 2021

BUY
$86.23 - $125.19 $344 - $500
4 New
4 $0

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $500M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Harbour Investments, Inc. Portfolio

Follow Harbour Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.